BAGIC grew GDPI 32.3% in Q4 vs industry 10.9%, gaining over 100bps market share to 8.3%.
Bajajfinsv Ltd — Q4 FY24
Bajaj Finserv reported a strong Q4 FY24 with consolidated total income up 36% YoY to INR 32,042 crore and PAT up 20% to INR 2,119 crore.
✓ Verified against BSE filing
2-Minute Summary
Bajaj Finserv reported a strong Q4 FY24 with consolidated total income up 36% YoY to INR 32,042 crore and PAT up 20% to INR 2,119 crore. The general insurance arm (BAGIC) grew gross written premium 32% YoY, significantly outpacing industry growth of 10.9%, though the combined ratio weakened to 101.6% from 97.3% due to higher claims. Life insurance (BALIC) delivered individual rated premium growth of 17% on a high base, with NBV up 16% to INR 480 crore. Bajaj Finance continued its robust performance with 25% revenue growth and 21% PAT growth. Management highlighted market share gains in both insurance businesses and expressed optimism about sustained growth driven by favorable macros and regulatory tailwinds. Key risks include competitive intensity in motor insurance, potential regulatory changes on surrender charges, and the cyclical nature of tender-driven government health and crop businesses.
बजाज फिनसर्व ने चौथी तिमाही में शानदार प्रदर्शन किया। कुल आय 36% बढ़कर 32,042 करोड़ रुपये हो गई, और मुनाफा 20% बढ़कर 2,119 करोड़ रुपये रहा। इसकी जनरल इंश्योरेंस कंपनी (BAGIC) का प्रीमियम 32% बढ़ा, जो उद्योग की 10.9% वृद्धि से कहीं ज्यादा है। हालांकि, ज्यादा क्लेम के कारण इसका खर्च-आय अनुपात बिगड़कर 101.6% हो गया। लाइफ इंश्योरेंस (BALIC) में नए कारोबार का मूल्य 16% बढ़कर 480 करोड़ रुपये रहा। बजाज फाइनेंस ने 25% राजस्व और 21% मुनाफा बढ़ाया। कंपनी को बाजार हिस्सेदारी बढ़ने और अर्थव्यवस्था के अनुकूल होने से आगे भी अच्छी वृद्धि की उम्मीद है। जोखिमों में मोटर इंश्योरेंस में प्रतिस्पर्धा और सरकारी योजनाओं पर निर्भरता शामिल है।
Key Numbers
BALIC grew IRP 17% in Q4 against flat industry and 2% private sector growth, on a high base.
NBV grew 16% in Q4 to INR 480 crore, reflecting operating leverage and scale benefits.
Combined ratio worsened to 101.6% from 97.3% due to higher claims, but full-year improved to 99.9%.
What Changed vs Last Quarter
Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given.
Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided.
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
Management expects continued strong growth in IRNB, with focus on product mix and channel diversification.
The company aims to grow faster than the industry in profitable segments, leveraging distribution expansion.
Deficiencies pointed out by RBI have been mostly cleared; disbursements expected to resume after regulatory approval.
No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.
Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.
37th month persistency dropped due to a specific partner bucket; 49th month may also be impacted, though overall persistency improving.
Motor insurance growth slowed to 5% due to competitive pricing and conservative underwriting stance.
Banks may prioritize deposits over third-party products, pressuring bancassurance growth.
Frequent Nat Cat events increased combined ratio to 102.9% in Q3; core profitability remains strong.
🤫 Topics management stopped discussing
Mentioned in Q1 FY24, Q2 FY24
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Mentioned in Q1 FY24, Q2 FY24
Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
Management Guidance
BAGIC to maintain above-market growth with balanced profitability
Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given.
Management guidance growthBALIC to grow faster than industry with improving margins
Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided.
Management guidance marginsBajaj Finserv Health to integrate Vidal acquisition in Q1 FY25
Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
Management guidance expansionKey Risks
Motor TP pricing uncertainty
No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.
high · analyst_questionRegulatory risk on surrender charges for life insurance
Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.
medium · analyst_questionDependence on tender-driven government health and crop business
Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.
medium · management_commentaryPersistency pressure in life insurance from older cohorts
37th month persistency dropped due to a specific partner bucket; 49th month may also be impacted, though overall persistency improving.
low · management_commentaryNotable Quotes
Bajaj continues to balance growth with profitability and consistently delivers a superior combined ratio versus the industry.
We are never into this rush of acquiring business just for the sake of acquiring business. It has to be done sensibly, because in generation business, it's a very long-term business.
The company has had a turnaround in the last 5-6 years. And we've moved into positive territory on margin about 5-6 years back, and the direction is only up.
Frequently Asked Questions
What was Bajajfinsv's revenue in Q4 FY24?
Bajajfinsv reported revenue of ₹32,041 Cr in Q4 FY24, representing a +36% change compared to the same quarter last year.
What guidance did Bajajfinsv management give for FY25?
BAGIC to maintain above-market growth with balanced profitability: Management expects continued market share gains driven by distribution expansion and prudent underwriting, but no specific growth target given. BALIC to grow faster than industry with improving margins: Directionally, NBV margins expected to improve due to scale and cost efficiencies, though no specific numbers provided. Bajaj Finserv Health to integrate Vidal acquisition in Q1 FY25: Acquisition completed in April 2024; integration and utilization of Vidal network to begin next quarter.
What are the key risks for Bajajfinsv in FY25?
Key risks include Motor TP pricing uncertainty — No price hike in motor third-party for years; frequency of accidents rising, and regulatory approval for hike is uncertain, especially in an election year.; Regulatory risk on surrender charges for life insurance — Regulator may reconsider surrender charge regulations; management declined to comment, indicating potential impact on product profitability.; Dependence on tender-driven government health and crop business — Growth in government health and crop is tender-based and pricing-dependent; management may lose share if pricing becomes unfavorable.; Persistency pressure in life insurance from older cohorts — 37th month persistency dropped due to a specific partner bucket; 49th month may also be impacted, though overall persistency improving..
Did Bajajfinsv meet its previous quarter's guidance?
Of 3 tracked promises, management 0 met, 0 close, 3 missed.
Where can I read the full Bajajfinsv Q4 FY24 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.